English
简体中文
Total: £ 56.28
Published Date: 2025-09-15 | Pages: 81 | Tables: 84 | Medical Care
The global market for RNA Next-Generation Sequencing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
RNA next-generation sequencing refer to the use of next-generation sequencing to reveal the presence and quantity of RNA in a biological sample at a given moment.
North American market for RNA Next-Generation Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for RNA Next-Generation Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for RNA Next-Generation Sequencing in Research Institutes is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of RNA Next-Generation Sequencing include Roche, Illumina, Thermo Fisher Scientific, Beckman Coulter, Abbott Molecular, Pacific Biosciences, Oxford Nanopore Technologies, Eurofins Scientific, Macrogen, GENEWIZ, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Next-Generation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Next-Generation Sequencing.
The RNA Next-Generation Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Next-Generation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Next-Generation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Illumina
Thermo Fisher Scientific
Beckman Coulter
Abbott Molecular
Pacific Biosciences
Oxford Nanopore Technologies
Eurofins Scientific
Macrogen
GENEWIZ
BGI
Berry Genomics
QIAGEN
Segment by Type
Enrichment Approaches
Amplicon-Based Approaches
Segment by Application
Research Institutes
Hospitals and Clinics
Biotechnology Company
Diagnostic Lab
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Next-Generation Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Next-Generation Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Enrichment Approaches
1.2.3 Amplicon-Based Approaches
1.3 Market by Application
1.3.1 Global RNA Next-Generation Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Institutes
1.3.3 Hospitals and Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Next-Generation Sequencing Market Perspective (2020-2031)
2.2 Global RNA Next-Generation Sequencing Growth Trends by Region
2.2.1 Global RNA Next-Generation Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 RNA Next-Generation Sequencing Historic Market Size by Region (2020-2025)
2.2.3 RNA Next-Generation Sequencing Forecasted Market Size by Region (2026-2031)
2.3 RNA Next-Generation Sequencing Market Dynamics
2.3.1 RNA Next-Generation Sequencing Industry Trends
2.3.2 RNA Next-Generation Sequencing Market Drivers
2.3.3 RNA Next-Generation Sequencing Market Challenges
2.3.4 RNA Next-Generation Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Next-Generation Sequencing Players by Revenue
3.1.1 Global Top RNA Next-Generation Sequencing Players by Revenue (2020-2025)
3.1.2 Global RNA Next-Generation Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global RNA Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNA Next-Generation Sequencing Revenue
3.4 Global RNA Next-Generation Sequencing Market Concentration Ratio
3.4.1 Global RNA Next-Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Next-Generation Sequencing Revenue in 2024
3.5 Global Key Players of RNA Next-Generation Sequencing Head office and Area Served
3.6 Global Key Players of RNA Next-Generation Sequencing, Product and Application
3.7 Global Key Players of RNA Next-Generation Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Next-Generation Sequencing Breakdown Data by Type
4.1 Global RNA Next-Generation Sequencing Historic Market Size by Type (2020-2025)
4.2 Global RNA Next-Generation Sequencing Forecasted Market Size by Type (2026-2031)
5 RNA Next-Generation Sequencing Breakdown Data by Application
5.1 Global RNA Next-Generation Sequencing Historic Market Size by Application (2020-2025)
5.2 Global RNA Next-Generation Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America RNA Next-Generation Sequencing Market Size (2020-2031)
6.2 North America RNA Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America RNA Next-Generation Sequencing Market Size by Country (2020-2025)
6.4 North America RNA Next-Generation Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Next-Generation Sequencing Market Size (2020-2031)
7.2 Europe RNA Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe RNA Next-Generation Sequencing Market Size by Country (2020-2025)
7.4 Europe RNA Next-Generation Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Next-Generation Sequencing Market Size (2020-2031)
8.2 Asia-Pacific RNA Next-Generation Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific RNA Next-Generation Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific RNA Next-Generation Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Next-Generation Sequencing Market Size (2020-2031)
9.2 Latin America RNA Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America RNA Next-Generation Sequencing Market Size by Country (2020-2025)
9.4 Latin America RNA Next-Generation Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Next-Generation Sequencing Market Size (2020-2031)
10.2 Middle East & Africa RNA Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa RNA Next-Generation Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa RNA Next-Generation Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche RNA Next-Generation Sequencing Introduction
11.1.4 Roche Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina RNA Next-Generation Sequencing Introduction
11.2.4 Illumina Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific RNA Next-Generation Sequencing Introduction
11.3.4 Thermo Fisher Scientific Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter RNA Next-Generation Sequencing Introduction
11.4.4 Beckman Coulter Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.4.5 Beckman Coulter Recent Development
11.5 Abbott Molecular
11.5.1 Abbott Molecular Company Details
11.5.2 Abbott Molecular Business Overview
11.5.3 Abbott Molecular RNA Next-Generation Sequencing Introduction
11.5.4 Abbott Molecular Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.5.5 Abbott Molecular Recent Development
11.6 Pacific Biosciences
11.6.1 Pacific Biosciences Company Details
11.6.2 Pacific Biosciences Business Overview
11.6.3 Pacific Biosciences RNA Next-Generation Sequencing Introduction
11.6.4 Pacific Biosciences Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.6.5 Pacific Biosciences Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Details
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies RNA Next-Generation Sequencing Introduction
11.7.4 Oxford Nanopore Technologies Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific RNA Next-Generation Sequencing Introduction
11.8.4 Eurofins Scientific Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.8.5 Eurofins Scientific Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen RNA Next-Generation Sequencing Introduction
11.9.4 Macrogen Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.9.5 Macrogen Recent Development
11.10 GENEWIZ
11.10.1 GENEWIZ Company Details
11.10.2 GENEWIZ Business Overview
11.10.3 GENEWIZ RNA Next-Generation Sequencing Introduction
11.10.4 GENEWIZ Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.10.5 GENEWIZ Recent Development
11.11 BGI
11.11.1 BGI Company Details
11.11.2 BGI Business Overview
11.11.3 BGI RNA Next-Generation Sequencing Introduction
11.11.4 BGI Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.11.5 BGI Recent Development
11.12 Berry Genomics
11.12.1 Berry Genomics Company Details
11.12.2 Berry Genomics Business Overview
11.12.3 Berry Genomics RNA Next-Generation Sequencing Introduction
11.12.4 Berry Genomics Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.12.5 Berry Genomics Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN RNA Next-Generation Sequencing Introduction
11.13.4 QIAGEN Revenue in RNA Next-Generation Sequencing Business (2020-2025)
11.13.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global RNA Next-Generation Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Enrichment Approaches
Table 3. Key Players of Amplicon-Based Approaches
Table 4. Global RNA Next-Generation Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global RNA Next-Generation Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global RNA Next-Generation Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global RNA Next-Generation Sequencing Market Share by Region (2020-2025)
Table 8. Global RNA Next-Generation Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global RNA Next-Generation Sequencing Market Share by Region (2026-2031)
Table 10. RNA Next-Generation Sequencing Market Trends
Table 11. RNA Next-Generation Sequencing Market Drivers
Table 12. RNA Next-Generation Sequencing Market Challenges
Table 13. RNA Next-Generation Sequencing Market Restraints
Table 14. Global RNA Next-Generation Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global RNA Next-Generation Sequencing Market Share by Players (2020-2025)
Table 16. Global Top RNA Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Next-Generation Sequencing as of 2024)
Table 17. Ranking of Global Top RNA Next-Generation Sequencing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by RNA Next-Generation Sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of RNA Next-Generation Sequencing, Headquarters and Area Served
Table 20. Global Key Players of RNA Next-Generation Sequencing, Product and Application
Table 21. Global Key Players of RNA Next-Generation Sequencing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global RNA Next-Generation Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global RNA Next-Generation Sequencing Revenue Market Share by Type (2020-2025)
Table 25. Global RNA Next-Generation Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global RNA Next-Generation Sequencing Revenue Market Share by Type (2026-2031)
Table 27. Global RNA Next-Generation Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global RNA Next-Generation Sequencing Revenue Market Share by Application (2020-2025)
Table 29. Global RNA Next-Generation Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global RNA Next-Generation Sequencing Revenue Market Share by Application (2026-2031)
Table 31. North America RNA Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America RNA Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America RNA Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe RNA Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe RNA Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe RNA Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific RNA Next-Generation Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific RNA Next-Generation Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific RNA Next-Generation Sequencing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America RNA Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America RNA Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America RNA Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa RNA Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa RNA Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa RNA Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche RNA Next-Generation Sequencing Product
Table 49. Roche Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Illumina Company Details
Table 52. Illumina Business Overview
Table 53. Illumina RNA Next-Generation Sequencing Product
Table 54. Illumina Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 55. Illumina Recent Development
Table 56. Thermo Fisher Scientific Company Details
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific RNA Next-Generation Sequencing Product
Table 59. Thermo Fisher Scientific Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Beckman Coulter Company Details
Table 62. Beckman Coulter Business Overview
Table 63. Beckman Coulter RNA Next-Generation Sequencing Product
Table 64. Beckman Coulter Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 65. Beckman Coulter Recent Development
Table 66. Abbott Molecular Company Details
Table 67. Abbott Molecular Business Overview
Table 68. Abbott Molecular RNA Next-Generation Sequencing Product
Table 69. Abbott Molecular Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 70. Abbott Molecular Recent Development
Table 71. Pacific Biosciences Company Details
Table 72. Pacific Biosciences Business Overview
Table 73. Pacific Biosciences RNA Next-Generation Sequencing Product
Table 74. Pacific Biosciences Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 75. Pacific Biosciences Recent Development
Table 76. Oxford Nanopore Technologies Company Details
Table 77. Oxford Nanopore Technologies Business Overview
Table 78. Oxford Nanopore Technologies RNA Next-Generation Sequencing Product
Table 79. Oxford Nanopore Technologies Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 80. Oxford Nanopore Technologies Recent Development
Table 81. Eurofins Scientific Company Details
Table 82. Eurofins Scientific Business Overview
Table 83. Eurofins Scientific RNA Next-Generation Sequencing Product
Table 84. Eurofins Scientific Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 85. Eurofins Scientific Recent Development
Table 86. Macrogen Company Details
Table 87. Macrogen Business Overview
Table 88. Macrogen RNA Next-Generation Sequencing Product
Table 89. Macrogen Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 90. Macrogen Recent Development
Table 91. GENEWIZ Company Details
Table 92. GENEWIZ Business Overview
Table 93. GENEWIZ RNA Next-Generation Sequencing Product
Table 94. GENEWIZ Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 95. GENEWIZ Recent Development
Table 96. BGI Company Details
Table 97. BGI Business Overview
Table 98. BGI RNA Next-Generation Sequencing Product
Table 99. BGI Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 100. BGI Recent Development
Table 101. Berry Genomics Company Details
Table 102. Berry Genomics Business Overview
Table 103. Berry Genomics RNA Next-Generation Sequencing Product
Table 104. Berry Genomics Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 105. Berry Genomics Recent Development
Table 106. QIAGEN Company Details
Table 107. QIAGEN Business Overview
Table 108. QIAGEN RNA Next-Generation Sequencing Product
Table 109. QIAGEN Revenue in RNA Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 110. QIAGEN Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. RNA Next-Generation Sequencing Picture
Figure 2. Global RNA Next-Generation Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global RNA Next-Generation Sequencing Market Share by Type: 2024 VS 2031
Figure 4. Enrichment Approaches Features
Figure 5. Amplicon-Based Approaches Features
Figure 6. Global RNA Next-Generation Sequencing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global RNA Next-Generation Sequencing Market Share by Application: 2024 VS 2031
Figure 8. Research Institutes Case Studies
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Biotechnology Company Case Studies
Figure 11. Diagnostic Lab Case Studies
Figure 12. RNA Next-Generation Sequencing Report Years Considered
Figure 13. Global RNA Next-Generation Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global RNA Next-Generation Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global RNA Next-Generation Sequencing Market Share by Region: 2024 VS 2031
Figure 16. Global RNA Next-Generation Sequencing Market Share by Players in 2024
Figure 17. Global Top RNA Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Next-Generation Sequencing as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by RNA Next-Generation Sequencing Revenue in 2024
Figure 19. North America RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America RNA Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 21. United States RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe RNA Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 25. Germany RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific RNA Next-Generation Sequencing Market Share by Region (2020-2031)
Figure 33. China RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America RNA Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 41. Mexico RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa RNA Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 45. Turkey RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE RNA Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 49. Illumina Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 51. Beckman Coulter Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 52. Abbott Molecular Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 53. Pacific Biosciences Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 54. Oxford Nanopore Technologies Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 55. Eurofins Scientific Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 56. Macrogen Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 57. GENEWIZ Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 58. BGI Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 59. Berry Genomics Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 60. QIAGEN Revenue Growth Rate in RNA Next-Generation Sequencing Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
